Summary Conjugated linoleic acid (CLA) is a collective term used for fatty acids with a conjugated double bond that are geometrical and positional isomers of linoleic acid. Antiobesity and anti-cancer properties, an immunopotentiation effect, and promotion of bone formation by CLA have been shown in cell culture and animal studies. A mixture of 9c11t-and 10t12c-CLA is now used as a health food supplement after testing in clinical trials. These trials focused on improvement of lipid metabolism by CLA, whereas few studies have examined absorption and metabolism of CLA in humans. In addition, there is no report concerning absorption and metabolism of CLA in Japanese. This study was designed to examine CLA concentration in blood, the elimination rate of CLA, and metabolic differences between 9c11t-CLA and 10t12c-CLA in blood in Japanese who ingested CLA (about 2 g/d, equal weights of 9c11t-CLA and 10t12c-CLA) for 3 wk. Blood samples were collected 1 wk before the 3-wk period, on the first and last days of the period, and 1 wk after the end of the period, and the CLA concentration and distribution in blood were investigated. The CLA concentration in blood was significantly increased by CLA ingestion and reached 36 mol/L. The CLA concentration in blood one week after the intake period was significantly lower than that at the end of CLA intake. The 10t12c-CLA level in plasma decreased faster than that of 9c11t-CLA. This suggests faster metabolism (fatty acid  oxidation) of 10t12c-CLA compared with 9c11t-CLA. Key Words conjugated fatty acid, CLA, conjugated linoleic acid, metabolism, human Conjugated linoleic acid (CLA) is a collective term used for fatty acids with a conjugated double bond that are geometrical and positional isomers of linoleic acid. CLA isomers with conjugated double bonds at positions 7 and 9, 8 and 10, 9 and 11, 10 and 12, and 11 and 13 are known, with the main natural CLA isomer having a 9-cis, 11-trans configuration (9c11t-CLA). Anti-obesity and anti-cancer properties, an immunopotentiation effect, and promotion of bone formation by CLA have been shown in cell culture and animal studies ( 1-4 ). A mixture of 9c11t-and 10t12c-CLA is now used as a health food supplement after testing in clinical trials ( 5-7 ). These trials focused on improvement of lipid metabolism by CLA, whereas few studies have examined absorption and metabolism of CLA in humans. However, animal studies suggest greater accumulation of 9c11t-CLA than 10t12c-CLA in vivo ( 8-10 ).Safe and effective use of CLA requires information on absorption and metabolism in humans. In this study, we measured CLA concentrations in blood, the rate of elimination of CLA, metabolic differences between 9c11t-and 10t12c-CLA, and CLA distribution in blood in healthy subjects who ingested CLA (about 2 g/d, equal weights of 9c11t-and 10t12c-CLA) for 3 wk. Blood samples were collected before and after the 3-wk period. The CLA concentration in blood increased after CLA ingestion, and decreased at one week after intake compared with at the end of CLA inta...